Development, Validation, and Application of a Scoring Model for Non-alcoholic Steatohepatitis

被引:0
|
作者
Xiao, Jinfeng [1 ]
Zhang, Xinxin [1 ]
Zhu, Chonggui [1 ]
Gu, Yian [1 ]
Sun, Longhao [2 ]
Liang, Xiaoyu [2 ]
He, Qing [1 ]
机构
[1] Tianjin Med Univ Gen Hosp, Dept Endocrinol & Metab, 154 Anshan Rd, Tianjin 300052, Peoples R China
[2] Tianjin Med Univ Gen Hosp, Dept Gen Surg, Tianjin 300052, Peoples R China
关键词
Non-alcoholic liver disease; Non-alcoholic steatohepatitis; Non-invasive score; Sleeve gastrectomy; FATTY LIVER-DISEASE; MORBIDLY OBESE SUBJECTS; BARIATRIC SURGERY; PREVALENCE; PREDICTORS; FIBROSIS; SPECTRUM; SYSTEM; FEATURES;
D O I
10.1007/s11695-023-06804-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose The aim of this study was to explore risk factors of NASH and then develop a non-invasive scoring model in Chinese patients with obesity. A scoring system was then applied to assess the effect of sleeve gastrectomy on NASH.Methods A total of 243 patients with obesity were included and divided into NASH group and non-NASH group according to the pathological results of liver biopsy. Logistic regression was used to determine risk factors of NASH. A scoring model was derived by risk factors of NASH. Then, postoperative follow-up was performed in 70 patients.Results Among the 243 patients, 118 (48.56%) patients showed NASH. Multivariate logistic regression identified aspartate aminotransferase (AST) (>21.50 IU/L), high-density lipoprotein cholesterol (HDL-C) (<1.155mmol/L), and homeostasis model assessment (HOMA-IR) (>9.368) as independent risk factors of NASH. The model included above risk factors showed a negative predictive value (NPV) of 70.38% in the low-risk category and a positive predictive value (PPV) of 85.71% in the high-risk category, with the area under the receiver operator curve (AUROC) of 0.737. Bariatric surgery resulted in a sharp decline in AST and HOMA-IR and a significant increase of HDL-C. The points of scoring model were improved at 6 months after surgery.Conclusion A non-invasive scoring model was derived by the risk factors of NASH included AST, HDL-C, and HOMA-IR and applied to the postoperative follow-up. After sleeve gastrectomy, the above risk factors and points of scoring model were significantly improved.
引用
收藏
页码:3246 / 3255
页数:10
相关论文
共 50 条
  • [21] Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis
    Berlanga, Alba
    Guiu-Jurado, Esther
    Antonio Porras, Jose
    Aragones, Gemma
    Auguet, Teresa
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (01): : 47 - 61
  • [22] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    [J]. DRUG RESEARCH, 2021, 71 : S16 - S18
  • [23] An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Marin, Veronica
    Rosso, Natalia
    Dal Ben, Matteo
    Raseni, Alan
    Boschelle, Manuela
    Degrassi, Cristina
    Nemeckova, Ivana
    Nachtigal, Petr
    Avellini, Claudio
    Tiribelli, Claudio
    Gazzin, Silvia
    [J]. PLOS ONE, 2016, 11 (07):
  • [24] Treatment of alcoholic and non-alcoholic steatohepatitis
    Stremmel, W
    Blechacz, B
    Herrmann, T
    Rost, D
    Mueller, S
    [J]. INTERNIST, 2001, 42 (12): : 1641 - +
  • [25] Combined alcoholic and non-alcoholic steatohepatitis
    Wandji, Line Carolle Ntandja
    Gnemmi, Viviane
    Mathurin, Philippe
    Louvet, Alexandre
    [J]. JHEP REPORTS, 2020, 2 (03)
  • [26] A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
    Lee, Kyoungbun
    Jung, Eun Sun
    Yu, Eunsil
    Kang, Yun Kyung
    Cho, Mee-Yon
    Kim, Joon Mee
    Moon, Woo Sung
    Jeong, Jin Sook
    Park, Cheol Keun
    Park, Jae-Bok
    Kang, Dae Ryong
    Sohn, Jin Hee
    Jin, So-Young
    [J]. JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2020, 54 (03) : 228 - 236
  • [27] The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Goh, George B. B.
    Issa, Danny
    Lopez, Rocio
    Dasarathy, Srinivasan
    Dasarathy, Jaividhya
    Sargent, Ruth
    Hawkins, Carol
    Pai, Rish K.
    Yerian, Lisa
    Khiyami, Amer
    Pagadala, Mangesh R.
    Sourianarayanane, Achuthan
    Alkhouri, Naim
    McCullough, Arthur J.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) : 995 - 1000
  • [28] Development of machine learning model to detect fibrotic non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Aggarwal, Manik
    Rozenbaum, Daniel
    Bansal, Agam
    Garg, Rajat
    Bansal, Parikshit
    McCullough, Arthur
    [J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 (12) : 1669 - 1672
  • [29] Validation of a diagnostic biomarker panel for non-alcoholic steatohepatitis (NASH)
    Younossi, Z. M.
    Jarrar, M.
    Nugent, C.
    Randhawa, M.
    Afendy, M.
    Stepanova, M.
    Afendy, A.
    Rafiq, N.
    Goodman, Z.
    Chandhoke, V.
    Baranova, A.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S14 - S15
  • [30] ROLE OF EPIGENETIC FACTORS IN NON-ALCOHOLIC STEATOHEPATITIS DEVELOPMENT
    Gallego-Duran, R.
    del Campo, J. A.
    Ampuero, J.
    Garcia-Valdecasas, M.
    Rojas, L.
    Pastor-Ramirez, H.
    Pareja, M. J.
    Millan, R.
    Rico, M. C.
    Gil-Gomez, A.
    Rojas, A.
    Rojas, A.
    Romero-Gomez, M.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S709 - S709